Human Metabolism of Bis(2-ethylhexyl)phthalate

Abstract

To study the human metabolism of bis (2-ethylhexyl)-phthalate (DEHP) urine samples were analyzed from non-uremic psoriatic patients, uremic patients undergoing hemodialysis treatments and patients undergoing cardiac bypass surgery using High Performance Liquid Chromatography (HPLC). The urine of dialyzed non-uremic patients contained phthalic acid, mono (2-ethylhexyl) phthalate and bis (2-ethylhexyl) phthalate. Other compounds identified were p-hydroxy benzoic acid, m-hydroxy benzoic acid, o-hydroxy hippuric acid, o-hydroxy benzoic acid and benzoic acid, which may be either diet dependent normal urinary constituents or metabolites of bis (2-ethylhexyl) phthalate. The levels of phthalic acid and bis (2-ethylhexyl) phthalate found in the urine of patients who were on total body oxygenators containing a membrane during cardiac bypass surgery were comparable to levels obtained from non-uremic psoriatic patients. Significant levels of phthalic acid were detected in the urine of the uremic patients studied while mono (2-ethylhexyl) phthalate and bis (2-ethylhexyl)-phthalate were present only in small amounts or were completely absent. In general, the urinary phthalate content of uremic patients increased with urinary volume.     

Determination of DEHP in blood products stored in plastic bags by HPLC

Summary High-performance liquid chromatography (HPLC) was used for the routine monitoring of the plasticizers di(2-ethylhexyl) phthalate (DEHP) and tri(2-ethylhexyl) trimellitate (TOTM), in blood products. It allows easy sample clean-up, solvent extraction using Celite 545 sorbent, good recoveries and opportunity to inject large number of samples without effect on column performance. The plasticizer levels were investigated in two types of poly(vinyl chloride) (PVC) bags containing whole blood plasma, platelet concentrates (PCs) during blood taking and storage.     

邻苯二甲酸二(2-乙基)己酯和偏苯三酸三辛酯在临床不同药液中溶出量的比较

聚氯乙烯(PVC)材质的医疗器械产品中需要加入增塑剂以改善柔韧性,目前最常用的增塑剂是邻苯二甲酸二(2-乙基)己酯(DEHP)和偏苯三酸三辛酯(TOTM)。本文考察了PVC一次性使用输液器产品在脂溶性药液(紫杉醇注射液)、肠外营养液(脂肪乳)、酸性药液(左氧氟沙星,pH 3.0~5.0)和碱性药液(呋塞米,pH 8.0~9.0)中的DEHP和TOTM溶出量,并进行对比分析。先建立了一种高效液相色谱-紫外检测(HPLC-UV)方法测定增塑剂的溶出量,并利用该方法对增塑剂的溶出量进行了分析。实验结果表明,增塑剂在不同药液中均有一定的溶出情况,其中紫杉醇注射液对增塑剂的溶出量要高于脂肪乳,并远高于左氧氟沙星和呋塞米注射液。通过对比DEHP和TOTM的溶出量可以看出,在相同的浸提条件下,TOTM的溶出量远低于DEHP的溶出量。利用紫杉醇注射液浸提24 h,PVC输液器产品DEHP的溶出量为21.14 mg,而TOTM的溶出量仅为0.078 mg。DEHP的溶出量为TOTM溶出量的270倍。因此,TOTM具有的较好耐迁移性,是一种潜在的DEHP替代增塑剂。     

An Improved HPLC Method for the Determination of Furosemide in Plasma and Urine

Abstract

A sensitive HPLC method with minimal sample preparation and good reproducibility for the determination of furosemide in plasma and urine is described. Acidified plasma samples were extracted using CH₂Cl₂ containing desmethylnaproxen as internal standard (IS). Fresh urine samples were incubated with β-gluc-uronidase for 15 minutes and then treated with CH₃CN containing IS.

Chromatography was performed on a C18 column with 10 mcl sample injection, Mobile phases were: a) for plasma: 0.01 M NaH₂PO₄, pH 3.5 - CH₃OH (65:35), and b) for urine: acetic acid, pH 3.5 - CHS3OH (60:40) at 3 ml/min and fluorescence detection at Ex 235/Em 389 nm. The plasma standard curve was linear from 0.01 to 15.0 mcg/ml and the urine from 0.5 to 200.0 mcg/ml. The within run CV's were 3,2% at 0.74 mcg/ml plasma and 2.0% at 10.7 mcg/ml urine. Recovery from plasma was 69.9% at 2.0 mcg/ml and 98.6% from urine at 5.0 mcg/ml. The stability of furosemide and its glucuronide were studied. Both methods have been applied to the analysis of plasma and urine samples obtained from human volunteers.     

Sensitive and selective determination of metabolically formed trans-dihydrodiols and phenols of benzo[a]pyrene in water and urine samples by HPLC with amperometric detection

A method has been developed to separate hydroxylated metabolites of the carcinogenic polycyclic aromatic hydrocarbon benzo[a]pyrene, i. e. trans-4,5-, 7,8-, 9,10-dihydrodiol and 1-, 3-, 7-, and 9-phenol, by HPLC with amperometric detection employing an isocratic methanol/water eluent (70:30, v/v) containing 0.5 g/L sulfuric acid and 1 g/L lithium perchlorate. Compared with the usually applied fluorescence (λ_ex = 265 nm, λ_em = 460 nm) and ultraviolet (λ = 265 nm) detection, the amperometric technique is about 2–12 times more sensitive for the determination of all metabolites investigated. The method was applied to the determination of the seven metabolites of benzo[a]pyrene in different water samples and in urine after solid-phase extraction (SPE). The results obtained by HPLC with amperometric detection after SPE enrichment from an aqueous extract of a soil sample and from the urine of a rat intragastrically treated with benzo[a]pyrene agreed well with the values determined with fluorescence and/or UV detection.     

Sensitive and selective determination of metabolically formed trans-dihydrodiols and phenols of benzo[a]pyrene in water and urine samples by HPLC with amperometric detection

A method has been developed to separate hydroxylated metabolites of the carcinogenic polycyclic aromatic hydrocarbon benzo[a]pyrene, i. e. trans-4,5-, 7,8-, 9,10-dihydrodiol and 1-, 3-, 7-, and 9-phenol, by HPLC with amperometric detection employing an isocratic methanol/water eluent (70:30, v/v) containing 0.5 g/L sulfuric acid and 1 g/L lithium perchlorate. Compared with the usually applied fluorescence (λ_ex = 265 nm, λ_em = 460 nm) and ultraviolet (λ = 265 nm) detection, the amperometric technique is about 2–12 times more sensitive for the determination of all metabolites investigated. The method was applied to the determination of the seven metabolites of benzo[a]pyrene in different water samples and in urine after solid-phase extraction (SPE). The results obtained by HPLC with amperometric detection after SPE enrichment from an aqueous extract of a soil sample and from the urine of a rat intragastrically treated with benzo[a]pyrene agreed well with the values determined with fluorescence and/or UV detection. Received: 20 December 1996 / Revised: 10 March 1997 / Accepted: 30 April 1997     

Synthesis of Novel New 2-(2-(4-((3,4-Dihydro-4-oxo-3-aryl quinazolin-2-yl)methyl)piperazin-1-yl)acetoyloxy)-2-phenyl Acetic Acid Esters

Stereoselective diazotization of (S)-2-amino-2-phenyl acetic acid (L-phenyl glycine) (4) with NaNO₂ in 6% H₂SO₄ in a mixture of acetone and water gave optically pure (S)-2-hydroxy-2-phenyl acetic acid (L-mandelic acid) (5). Esterification, gave (S)-2-hydroxy-2-phenyl acetic acid esters (6). The latter was treated with chloroacetyl chloride in the presence of triethylamine (TEA) in dichloromethane (DCM) to yield (S)-2-chloroacetyloxy phenyl acetic acid ester (2). In another sequence, the reaction of 2-(chloromethyl)-3-arylquinazolin-4(3H)-one (9) treated with N-Boc piperazine, followed by deprotection of the Boc group, to obtain 3-aryl-2-((piperazin-1-yl)methyl) quinazolin-4(3H)-one (3). Reaction of 2 with 3 in the presence of K₂CO₃ and KI gave the title compound, 2-(2-(4-((3,4-dihydro-4-oxo-3-arylquinazolin-2-yl)methyl)piperazin-1-yl) acetoyloxy)-2-phenyl acetic acid esters (1). The structures of all the new compounds obtained in the present work are supported by spectral and analytical data.     

超高效液相色谱-三重四极杆质谱法测定人尿中9种邻苯二甲酸酯代谢物

建立了人尿中9种邻苯二甲酸酯（PAE）代谢物的超高效液相色谱-三重四极杆质谱（UPLC-MS/MS）测定方法。2 mL尿液样本酶解2 h后,经强阴离子固相萃取净化处理;选用Waters ACQUITY UPLC BEH Phenyl色谱柱（100 mm×2.1 mm,1.7 μ m）,以0.1%（体积分数）乙酸乙腈和0.1%（体积分数）乙酸水溶液为流动相进行梯度洗脱;在负离子电喷雾多反应监测模式（MRM）下测定9种PAE代谢物含量。8种PAE代谢物在0.39~200 μ g/L范围内、1种PAE代谢物在1.17~600 μ g/L范围内线性关系良好,相关系数均大于0.995。方法检出限为0.06~0.85 μ g/L,定量限为0.20~2.80 μ g/L。3个加标水平的加标回收率为84.1%~122%,精密度为4.5%~14.3%;日内精密度不高于9.3%,日间精密度不高于10.1%;基质效应和稳定性符合分析要求。应用该方法测定50份人尿液样本,邻苯二甲酸单环已酯（MCHP）和邻苯二甲酸单苄酯（MBZP）的检出率分别为0和44.0%,其余7种PAE代谢物的检出率为100%。该方法操作简单、定量准确、稳定性好,适用于人尿中9种PAE代谢物的定量分析。     

The Identification of Drugs of Abuse in Urine Using Reverse Phase High Pressure Liquid Chromatography

Abstract

A rapid, isocratic HPLC procedure for the identification of drugs of abuse in urine is described. The procedure utilizes a reverse phase μC₁₈ column, a methanol/water mobile phase, buffered to pH 7.5, and a UV detector operating at 254 nm. Using indole as an external standard, 13 common drugs of abuse can be differentiated in less than 15 minutes. Nine different drugs of abuse were identified in actual drug screen urine samples, confirming TLC results. Reproducibility and quantitative capabilities of this method were also demonstrated. Due to apparent interferences from drug metabolites this method must at present be used in conjunction with another established method such as TLC or GC for positive drug identification.     

Study on Determination of Six Transition Metal Ions in Biological Samples by SPE and RP‐HPLC

This paper reports the utilization of solid phase extraction and the reversed‐phase high‐performance liquid chromatography (RP‐HPLC) for the determination of six transition metal ions (iron, cobalt, nickel, copper, zinc and manganese) in biological samples. The samples were digested by microwave digestion. The iron, cobalt, nickel, copper, zinc and manganese ions in the digested samples can react with 2‐(2‐quinolinylazo)‐5‐diethylaminophenol (QADEAP) to form colored chelates in pH 4.0 acetic acid‐sodium acetic buffer solutions and cetyl trimethylammonium bromide (CTMAB) medium. These chelates were enriched by solid phase extraction with C₁₈ cartridge. Then the chelates were separated on a Waters Nova‐Pak‐C₁₈ column (3.9 × 150 mm, 5 μm) by gradient elution with methanol (containing 0.5% of acetic acid and 0.1% of CTMAB) and 0.05 mol/L pH 4.0 acetic acid‐sodium acetic buffer solution (containing 0.1% of CTMAB) as mobile phase at a flow rate of 0.5 mL/min. The detection limits of iron, cobalt, nickel, copper, zinc and manganese are 3 ng/L, 4 ng/L, 2 ng/L, 4 ng/L, 8 ng/L, 10 ng/L, respectively. This method was applied to the determination of iron, cobalt, nickel, copper, zinc and manganese in biological samples with good results.     

Simultaneous Analysis of Cimetidine and Ranitidine in Human Plasma by HPLC

Abstract

A rapid method for the simultaneous quantitation of the H₂-receptor antagonist drugs cimetidine and ranitidine in human plasma by isocratic ion-pair reverse-phase HPLC is described. The method involves a simple organic extraction step of the alkalinized plasma containing added internal standard followed by back extraction of the extract with dilute acetic acid and subsequent analysis of the aqueous acidic phase on a reverse-phase (C18) column. The eluting solvent was acetonitrile-water (20:80 v/v) containing 0.005 mole/litre octanesulphonic acid and was monitored at 229 nm. The run time for the assay was 12.5 minutes, with a detection limit for cimetidine of 50 ng/m1/(0.2 μmole/1) and that for ranitidine was 20 ng/ml (0.06 umole/1).     

Synthesis of an electro-catalyst based on a cobalt(II) complex with dimethylaminoethylamino-N,N-bis(2-methylene-4-tert-butyl-6-methylphenol)

A catalyst based on [LCo(H₂O)] (1) is formed by the reaction of dimethylaminoethylamino-N,N-bis(2-methylene-4-tert-butyl-6-methyl)phenol (H₂L) with CoBr₂ for electrolytic proton or water reduction. 1 catalyzes hydrogen evolution, both from acetic acid with a turnover frequency (TOF) of 17.9 mol of hydrogen per mole of catalyst per hour at an overpotential of 792 mV (in DMF) and from water with a TOF of 260 mol of hydrogen per mole of catalyst per hour at an overpotential of 889 mV (in buffer, pH 7.0).     

The Antibacterial and Larvicidal Potential of Bis-(2-Ethylhexyl) Phthalate from Lactiplantibacillus plantarum

Lactic acid bacteria produce a variety of antibacterial and larvicidal metabolites, which could be used to cure diseases caused by pathogenic bacteria and to efficiently overcome issues regarding insecticide resistance. In the current study, the antibacterial and larvicidal potential of Bis-(2-ethylhexyl) phthalate isolated from Lactiplantibacillus plantarum BCH-1 has been evaluated. Bioactive compounds were extracted by ethyl acetate and were fractionated by gradient column chromatography from crude extract. Based on FT-IR analysis followed by GC-MS and ESI-MS/MS, the active compound was identified to be Bis-(2-ethylhexyl) phthalate. Antibacterial potential was evaluated by disk diffusion against E. coli (12.33 ± 0.56 mm inhibition zone) and S. aureus (5.66 ± 1.00 mm inhibition zone). Larvicidal potency was performed against Culex quinquefasciatus Say larvae, where Bis-(2-ethylhexyl) phthalate showed 100% mortality at 250 ppm after 72 h with LC₅₀ of 67.03 ppm. Furthermore, after 72 h the acetylcholinesterase inhibition was observed as 29.00, 40.33, 53.00, 64.00, and 75.33 (%) at 50, 100, 150, 200, and 250 ppm, respectively. In comet assay, mean comet tail length (14.18 ± 0.28 μm), tail DNA percent damage (18.23 ± 0.06%), tail movement (14.68 ± 0.56 µm), comet length (20.62 ± 0.64 µm), head length (23.75 ± 0.27 µm), and head DNA percentage (39.19 ± 0.92%) were observed at 250 ppm as compared to the control. The current study for the first time describes the promising antibacterial and larvicidal potential of Bis-(2-ethylhexyl) phthalate from Lactiplantibacillus plantarum that would have potential pharmaceutical applications.     

Simultaneous Determination of Tin,Nickel, Lead,Cadmium and Mercury in Tobacco and Tobacco Additives by Microwave Digestion and RP‐HPLC Followed by On‐Line Column Enrichment

A new method for the simultaneous determination of five heavy metal ions, tin, nickel, lead, cadmium and mercury ions as metal‐tetra‐(2‐aminophenyl)‐porphyrin (T₂APP) chelates was developed using reversed‐phase high performance liquid chromatography (RP‐HPLC) equipped with a photodiode array detector and combined with an on‐line enrichment technique. The tin, nickel, lead, cadmium and mercury ions were pre‐column derivatized with T₂APP to form color chelates. The Sn‐T₂APP, Ni‐T₂APP, Hg‐T₂APP, Cd‐T₂‐APP and Pb‐T₂APP chelates can be absorbed onto the front of the enrichment column when they are injected into the injector and sent to the enrichment column [Waters Xterra? RP₁₈(5μ, 3.9 × 20 mm)] with a buffer solution of 0.05 mol/L pyrrolidine‐acetic acid (pH = 10.0) as mobile phase. After the enrichment had finished, by switching the six‐port switching valves, the retained chelates were back‐flushed by mobile phase and traveling towards the analytical column. These chelates separation on the analytical column [Waters Xterra? RP₁₈ (5μ, 3.9 × 150 mm)] was satisfactory by gradient elution with methanol (containing 0.05 mol/L pyrrolidine‐acetic acid buffer salt, pH = 10.0) and acetone (containing 0.05 mol/L pyrrolidine‐acetic acid buffer salt, pH = 10.0) as mobile phase. The linearity range is 0.01?120 μg/L for each metal ion. The detection limits (S/N = 3) of tin, nickel, lead, cadmium and mercury are 4.0 ng/L, 3.5 ng/L, 2.5 ng/L, 3.0 ng/L and 3.0 ng/L, respectively. This method was applied to the determination of tin, nickel, lead, cadmium and mercury ions in tobacco and tobacco additives with good results.     

Determination of Urinary Bis(2-ethylhexyl)phthalate Levels in Non-uremic Subjects by Gas Chromatography

Abstract

In vivo studies of urinary bis(2-ethylhexyl)phthalate (DEHP) levels in dogs and in non-uremic patients undergoing hemodialysis treatments for psoriasis were undertaken. Dogs were divided into 3 groups: Control, Sham-Operated, and Nephrectomized. Each dog received 225 mg DEHP per kilogram body weight via the femoral vein. Each of the non-uremic patients underwent hemodialysis therapy for 4–5 hours once a week for four consecutive weeks to treat their psoriatic condition. Specimens of 2 4 hr urine were collected and analyzed for DEHP by gas chromatography. The detection limit of DEHP in urine is 15 ng/ml. No detectable DEHP was found in the urine of all pre-injection specimens obtained from all three groups of dogs. The total urinary DEHP concentrations for the four day period were found to be 76.1 and 192.2 μg for the Control and the Sham-Operated dogs, respectively. No urine samples could be collected from the Nephrectomized dogs. DEHP levels were found in the 24 hr urine specimens from some of the non-uremic patients undergoing hemodialysis therapy. The DEHP concentrations ranged from non-detectable to 159.8 yg/24 hrs. Normal renal function seems to be necessary for the excretion of non-metabolized DEHP.     

An Improved Technique for Extraction,Identification, and Quantification of Leukotrienes

Abstract

An improved method for extraction, separation and quantification of leukotrienes is described. Critical steps include extraction in thoroughly cleaned Sep-Pak C₁₈ mini columns, elution with 90 percent methanol in water, addition of 0.25 percent Na₄EDTA to the solvent system of methanol/water 60/40, pH 7.4, injection of the samples in 1 ml of the same system after lowering the pH to 3.0 with glacial acetic acid and utilization of a Z-module containing a 5 μm C₁₈ reverse phase cartridge. Recovery of the leukotrienes was 94 pm 8% mean pm SD for LTC₄, 89 pm 5% for LTD₄, 89 pm 3% for LTB₄ and 84 pm 6% for LTE₄. We had no problems with precipitation of Na₄EDTA and occlusion of the HPLC fittings. The method is simple, reproducible and easily adaptable to any research laboratory.     

钴离子在P507为载体的支撑液膜中的传输

本文用国内的膜材料设计了以2-乙基已基膦酸单(2-乙基已基)酯(HEH(EHF),P_(507))为载体的支撑液膜迁移钴的实验,获得的数据为深入实验提供了依据.基本原理支撑液膜(SLM)是依靠微孔塑料薄膜(支撑体)微孔的毛细管作用将含萃取剂(载体)的有机溶液吸附在支撑体上.P_(507)萃取钴表示为:     

葛根提取物高效液相色谱分析方法的优化

针对葛根提取物的复杂体系,分别从色谱模式、流动相、添加剂以及梯度洗脱条件几个方面对其高效液相色谱分析 方法进行了优化。其中梯度洗脱条件的优化是根据各组分在5次线性梯度下的保留时间并借助于CSASS软件快速准确地计 算出各组分的液相色谱保留参数a,c值以及峰形参数σ和τ,在此基础上使用CSASS软件对葛根提取物的色谱分离情况进行 高精度仿真预测,从而优化了梯度洗脱条件。考察了优化条件下的分析方法的精密度和重现性,结果表明该方法稳定、可 靠、重现性好。     

Determination of clozapine and its metabolites in serum and urine by reversed phase HPLC

A rapid, specific and sensitive method using reversed phase HPLC for the simultaneous determination of clozapine and its two metabolites in serum and urine has been developed. The mobile phase was a mixture of 67% (v/v) methanol in water containing 0.4% tetramethylethylenediamine and 0.32% acetic acid (pH 5.5). The influence of methanol content, the pH of the mobile phase and the effect of adding alkylammonium ions as peak tailing reducer in the mobile phase have been investigated. The solvent for extracting clozapine from serum and urine was ether. 50 microliters of 0.25 M H2SO4 solution was used to redissolve the dry residue to eliminate the endogenous compounds which could otherwise be eluted together with clozapine from the HPLC column. The analysis of a single sample was accomplished within half an hour. The identities of the chromatographic peaks of clozapine and its N-demethyl metabolite collected from the patient urine sample were confirmed by mass spectrometry. The method is sufficiently sensitive (5 ng/ml) and reproducible (CV 2.9%-6.7%) for clinical and pharmacokinetic studies, and preliminary results in these respects are presented.     

β-(Methoxy-(substitutedphenyl)-methyl)-γ-butyrolactones: A short synthesis from cinnamyl acetate

A simple and short synthesis has been revealed for the preparation of (±) β-(Methoxy-(substitutedphenyl)-methyl)-γ-butyrolactones. The reaction of cinnamyl acetate with Mn(OAc)₃ · 2H₂O in boiling acetic acid containing acetic anhydride gave the products 2 and 3, which further cyclized in 3% H₂SO₄/CH₃OH to afford the butyrolactones (8a–e), which are intermediates of lignin, in good to moderate yields.